AbCellera Biologics (ABCL) Retained Earnings (2020 - 2026)
AbCellera Biologics' (ABCL) quarterly Retained Earnings came in at -$2.4 million in Q1 2026, up 65.43% YoY from -$1.5 million in Q1 2025, and up 91.79% on a QoQ basis from -$29.5 million in Q4 2025.
AbCellera Biologics (ABCL) Retained Earnings (2020 - 2026) Analysis & Trends
AbCellera Biologics (ABCL) has 7 years of Retained Earnings data on file, last reported at -$2.4 million in Q1 2026.
- Quarterly Retained Earnings rose 65.43% year-over-year to -$2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.4 million (up 65.43% YoY) and the FY2025 annual result came in at -$29.5 million, down 573.41% from the prior year.
- Retained Earnings climbed to -$2.4 million in Q1 2026, from -$29.5 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $436.2 million in Q1 2022 to a low of -$29.5 million in Q4 2025.
- A 5-year average of $96.8 million and a median of -$1.5 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings tumbled 596.79% — and 2023, when it surged 20214.09%.
- Tracing ABCL's Retained Earnings over 5 years: stood at -$1.4 million in 2022, then jumped by 20214.09% to $279.8 million in 2023, then sank by 101.56% to -$4.4 million in 2024, then slumped by 573.41% to -$29.5 million in 2025, then soared by 91.79% to -$2.4 million in 2026.
- The last three Retained Earnings figures came in at -$2.4 million (Q1 2026), -$29.5 million (Q4 2025), and -$20.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | AbCellera Biologics | 3.49 Bn | 3.49 Bn | - | -128.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -128.07 Mn |
| Mar 31, 2026 | -2.42 Mn |
| Dec 31, 2025 | -29.48 Mn |
| Sep 30, 2025 | -20.54 Mn |
| Jun 30, 2025 | 36.58 Mn |
| Mar 31, 2025 | -7.00 Mn |
| Dec 31, 2024 | -4.38 Mn |
| Sep 30, 2024 | 151.14 Mn |
| Jun 30, 2024 | -2.07 Mn |
| Mar 31, 2024 | -1.82 Mn |
| Dec 31, 2023 | 279.79 Mn |
| Sep 30, 2023 | -1.46 Mn |
| Jun 30, 2023 | -1.90 Mn |
| Mar 31, 2023 | 386.08 Mn |
| Dec 31, 2022 | -1.39 Mn |
| Sep 30, 2022 | -717,000.00 |
| Jun 30, 2022 | 429.45 Mn |
| Mar 31, 2022 | 436.24 Mn |
| Dec 31, 2021 | 280,000.00 |
| Sep 30, 2021 | 207.72 Mn |